Mechanism
Live attenuated bacterial immunotherapeutic
Assets acting on this target.
- Class
- Live attenuated bacterial immunotherapeutic (gamma-delta T-cell activator platform)
- Pathway
- Engineered bacterial strain delivers signals that activate endogenous gamma-delta (Vgamma9Vdelta2) T cells for anti-leukemic cytotoxicity, without a discrete molecular drug target
- Notes
- original target text: Live attenuated bacterial immunotherapeutic (gamma-delta T-cell activator platform)
Research
Sign in to access ResearchExplore this mechanism at different depths
Research adds deeper and simplified explanation variants while preserving the same scientific register and source caveats.
0 of 0 assets
No assets match these filters.